THCT OTC
THC Therapeutics, Inc.
1W: -50.0%
1M: -50.0%
3M: -66.7%
YTD: +200.0%
1Y: -40.0%
3Y: +1300.0%
5Y: -80.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$1K
+88.7% ▲
Operating Income
-$494K
+71.7% ▲
Net Income
-$387K
+74.5% ▲
EPS (Diluted)
$-0.01
+74.2% ▲
EBITDA
-$493K
+71.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $26K | $20K | $16K | $12K | $1K |
| Gross Profit | -$26K | -$20K | -$16K | -$12K | -$1K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $24M | $1M | $940K | $2M | $494K |
| Operating Expenses | $24M | $1M | $940K | $2M | $494K |
| Operating Income | -$27M | -$1M | -$940K | -$2M | -$494K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $304K | $488K | $552K | $100K | $80K |
| Income Before Tax | -$23M | -$2M | -$2M | -$2M | -$387K |
| Tax Expense | $304K | $488K | $0 | $0 | $0 |
| Net Income | -$24M | -$2M | -$2M | -$2M | -$387K |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-1.77 | $-0.15 | $-0.08 | $-0.05 | $-0.01 |
| EBITDA | -$24M | -$1M | -$924K | -$2M | -$493K |
| Shares Outstanding | 13M | 17M | 24M | 33M | 33M |